Consequences of delayed therapy with second-line agents in rheumatoid arthritis – a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study - Tsukanas, E; Fitzgerald, AA; Fitzcharles, MA (J Rheumatol, 2000)
(3)